R. Sprenger

Pneumococcal vaccination rates in immunocompromised patients—A cohort study based on claims data from more than 200,000 patients in Germany

C. von Eiff, J. Walker, D. Häckl, 2019, PloS one.

Pneumococcal vaccination rates in immunocompromised patients in Germany: A retrospective cohort study to assess sequential vaccination rates and changes over time

C. von Eiff, D. Häckl, N. Kossack, 2022, PloS one.

Population-based incidence and mortality of community-acquired pneumonia in Germany

C. von Eiff, J. Walker, C. Theilacker, 2021, PloS one.

The Impact of 7-valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease: A Literature Review

P. Balmer, E. Bonnet, T. Myint, 2013, Advances in Therapy.

Cost-effectiveness of use of 20-valent pneumococcal conjugate vaccine among adults in Germany

C. Theilacker, M. Atwood, F. Pueschner, 2023, medRxiv.

Nasopharyngeal Carriage in Children After the Introduction of Generalized Infant Pneumococcal Conjugate Vaccine Immunization in Germany

M. Rose, M. Laurenz, M. P. van der Linden, 2021, Frontiers in Medicine.

Mathematical modeling of pneumococcal transmission dynamics in response to PCV13 infant vaccination in Germany predicts increasing IPD burden due to serotypes included in next-generation PCVs

M. Scholz, M. P. van der Linden, E. Mahar, 2023, PloS one.